CJC 1295 With Dac
Overview CJC‑1295 with DAC (Drug Affinity Complex) is a long‑acting synthetic peptide analog of growth hormone–releasing hormone (GHRH). The DAC modification allows extended binding to plasma proteins, supporting a prolonged stimulation of the body’s natural growth hormone secretion. CJC‑1295 with DAC is designed to maintain more sustained GH signaling compared to shorter‑acting GHRH peptides.
Key Benefits
Sustained Endogenous GH Release
Supports prolonged stimulation of natural growth hormone secretion
Designed for extended GH signaling due to DAC technology
Muscle Support & Recovery
Involved in pathways related to lean muscle maintenance and tissue repair
Supports recovery processes influenced by growth hormone activity
Fat Metabolism Support
Associated with metabolic pathways related to lipid utilization
Supports overall body composition management
Anti‑Aging & Regenerative Support
Linked to GH‑dependent processes such as collagen production and cellular regeneration
Supports connective tissue and skin health pathways
Specifications
Peptide Type: Long‑acting GHRH analog
Form: Lyophilized powder
Purity: Pharmaceutical‑grade peptide
Release Profile: Extended‑duration activity due to DAC modification
Usage:
Typically reconstituted with bacteriostatic water and administered via subcutaneous injection under professional guidance.